1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. NEOLEUKIN THERAPEUTICS INC

Neoleukin Therapeutics Inc

XNAS: NLTX

Watchlist

Portfolio

Share


Insider Trading disclosures for Neoleukin Therapeutics Inc

The latest disclosure was made by Sean Smith in Neoleukin Therapeutics Inc where a trade of 1,323 Common Stock done at an average price of $0.6 was reported to US exchanges on Aug. 10, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sean Smith Interim CFO, Prin Acct Off Sale of securities on an exchange or to another person at price $ 0.62 per share. 10 Aug 2023 1,323 21,637 (0%) 0% 0.6 818 Common Stock
Sean Smith Interim CFO, Prin Acct Off Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2023 5,000 22,960 (0%) 0% 0 Common Stock
Sean Smith Interim CFO, Prin Acct Off Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2023 5,000 0 - - Restricted Stock Units
Martin Babler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (Right to Buy)
Rohan Palekar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (Right to Buy)
Todd E. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (Right to Buy)
Erin M. Lavelle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (Right to Buy)
Priti Patel Former Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 10,000 0 - - Restricted Stock Units
Priti Patel Former Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Mar 2023 10,000 41,082 (0%) 0% 0 Common Stock
Priti Patel Former Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.69 per share. 31 Mar 2023 3,769 37,313 (0%) 0% 0.7 2,608 Common Stock
Priti Patel Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 35,000 35,000 - - Restricted Stock Units
Priti Patel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 0.60 per share. 01 Feb 2023 14,380 31,082 (0%) 0% 0.6 8,588 Common Stock
Priti Patel Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 35,000 45,462 (0%) 0% 0 Common Stock
Sean Smith Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 12,500 19,276 (0%) 0% 0 Common Stock
Sean Smith Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2023 12,500 12,500 - - Restricted Stock Units
Sean Smith Principal Accounting Officer Sale of securities on an exchange or to another person at price $ 0.60 per share. 01 Feb 2023 3,316 15,960 (0%) 0% 0.6 1,980 Common Stock
Jonathan G. Drachman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 350,000 350,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 150,000 150,000 - - Stock Option (Right to Buy)
Priti Patel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 250,000 250,000 - - Stock Option (Right to Buy)
Sean Smith Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 150,000 150,000 - - Stock Option (Right to Buy)
Donna Cochener General Counsel, SVP Legal Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 100,000 100,000 - - Stock Option (Right to Buy)
Martin Babler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 25,000 25,000 - - Stock Option (Right to Buy)
Rohan Palekar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 25,000 25,000 - - Stock Option (Right to Buy)
Todd E. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 25,000 25,000 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 25,000 25,000 - - Stock Option (Right to Buy)
Erin M. Lavelle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 25,000 25,000 - - Stock Option (Right to Buy)
Priti Patel Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 10,000 12,000 (0%) 0% 0 Common Stock
Priti Patel Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.22 per share. 30 Apr 2022 5,538 6,462 (0%) 0% 1.2 6,749 Common Stock
Priti Patel Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2022 10,000 10,000 - - Restricted Stock Units
Donna Cochener General Counsel, SVP Legal Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2022 400,000 400,000 - - Stock Option (Right to Buy)
Rohan Palekar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2022 50,000 50,000 - - Stock Option (Right to Buy)
Sean Smith Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2022 80,000 80,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 55,000 55,000 - - Restricted Stock Units
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 70,000 70,000 - - Restricted Stock Units
Priti Patel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 70,000 70,000 - - Restricted Stock Units
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 6.45 per share. 24 Aug 2021 25,000 25,000 (0%) 0% 6.4 161,225 Common Stock
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 6.45 per share. 24 Aug 2021 25,000 25,000 (0%) 0% 6.4 161,225 Common Stock
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 6.11 per share. 24 Aug 2021 100,000 2,348,686 (4%) 0% 6.1 611,100 Common Stock
Jonathan G. Drachman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 400,000 400,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 100,000 100,000 - - Stock Option (Right to Buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 190,000 190,000 - - Stock Option (Right to Buy)
Holly Vance General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 100,000 100,000 - - Stock Option (Right to Buy)
Priti Patel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2021 50,000 50,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 10.19 per share. 16 Jun 2021 600 1,352,489 (2%) 0% 10.2 6,114 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 10.82 per share. 09 Jun 2021 650 1,353,089 (2%) 0% 10.8 7,036 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.00 per share. 08 Jun 2021 600 1,353,739 (2%) 0% 11 6,600 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 10.00 per share. 04 Jun 2021 600 1,354,339 (2%) 0% 10 6,000 Common Stock
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.61 per share. 03 Jun 2021 10,000 2,248,686 (4%) 0% 9.6 96,082 Common Stock
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.48 per share. 03 Jun 2021 40,000 2,238,686 (4%) 0% 9.5 379,272 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 10.00 per share. 26 May 2021 600 1,354,939 (2%) 0% 10 6,000 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 10.63 per share. 19 May 2021 600 1,355,539 (2%) 0% 10.6 6,378 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.09 per share. 12 May 2021 1,200 1,354,762 (2%) 0% 11.1 13,308 Common Stock
Martin Babler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 25,000 25,000 - - Stock Option (Right to Buy)
Todd E. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 25,000 25,000 - - Stock Option (Right to Buy)
Lewis T. Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 25,000 25,000 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 25,000 25,000 - - Stock Option (Right to Buy)
Erin M. Lavelle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 25,000 25,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.30 per share. 05 May 2021 1,200 1,355,962 (2%) 0% 11.3 13,560 Common Stock
Priti Patel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 20,000 20,000 - - Restricted Stock Units
Priti Patel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 475,000 475,000 - - Stock Option (Right to Buy)
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.58 per share. 28 Apr 2021 2,400 1,357,162 (2%) 0% 12.6 30,192 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 13.00 per share. 26 Apr 2021 600 1,359,562 (2%) 0% 13 7,800 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.98 per share. 21 Apr 2021 1,800 1,360,162 (2%) 0% 12.0 21,564 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.22 per share. 14 Apr 2021 1,800 1,361,962 (2%) 0% 12.2 21,996 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.02 per share. 07 Apr 2021 1,800 1,363,762 (2%) 0% 12.0 21,636 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 13.00 per share. 05 Apr 2021 600 1,365,562 (2%) 0% 13 7,800 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.96 per share. 31 Mar 2021 1,800 1,366,162 (2%) 0% 12.0 21,528 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.95 per share. 22 Mar 2021 1,800 1,367,962 (2%) 0% 12.0 21,516 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.00 per share. 22 Mar 2021 600 1,369,762 (2%) 0% 12 7,200 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.36 per share. 17 Mar 2021 1,200 1,370,362 (2%) 0% 11.4 13,632 Common Stock
Robert Ho Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 28,000 (0%) 0% 0 Common Stock
Robert Ho Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 25,000 50,000 - - Restricted Stock Units
Robert Ho Chief Financial Officer Sale of securities on an exchange or to another person at price $ 11.01 per share. 16 Mar 2021 6,497 21,503 (0%) 0% 11.0 71,556 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.97 per share. 10 Mar 2021 1,800 1,371,562 (2%) 0% 12.0 21,540 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 11.87 per share. 03 Mar 2021 1,800 1,373,362 (2%) 0% 11.9 21,360 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 13.00 per share. 24 Feb 2021 600 1,375,162 (2%) 0% 13 7,800 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.14 per share. 24 Feb 2021 1,800 1,375,762 (2%) 0% 12.1 21,852 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 12.70 per share. 17 Feb 2021 2,400 1,377,562 (2%) 0% 12.7 30,480 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 14.20 per share. 10 Feb 2021 3,000 1,379,962 (2%) 0% 14.2 42,600 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 14.00 per share. 05 Feb 2021 600 1,382,962 (2%) 0% 14 8,400 Common Stock
Carl Walkey Senior Vice President Sale of securities on an exchange or to another person at price $ 13.23 per share. 03 Feb 2021 2,400 1,383,562 (2%) 0% 13.2 31,752 Common Stock
Carl Walkey Senior Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jan 2021 45,000 45,000 - - Stock Option (Right to Buy)
Holly Vance General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2020 220,000 220,000 - - Stock Option (Right to Buy)
Martin Babler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Sep 2020 50,000 50,000 - - Stock Option (Right to Buy)
Jonathan G. Drachman Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2020 420,000 420,000 - - Stock Option (Right to Buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2020 90,000 90,000 - - Stock Option (Right to Buy)
Erin Lavelle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
Todd E. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 25,000 25,000 - - Stock Option (Right to Buy)
Lewis T. Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 25,000 25,000 - - Stock Option (Right to Buy)
Sean P. Nolan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 25,000 25,000 - - Stock Option (Right to Buy)
Sarah B. Noonberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2020 25,000 25,000 - - Stock Option (Right to Buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 200,000 200,000 - - Stock Option (Right to Buy)
Robert Ho Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2020 75,000 75,000 - - Restricted Stock Units
Jonathan G. Drachman Director, President and CEO 12 Nov 2019 12,616 0 (0%) 0% 0 Series A Preferred Stock
Jonathan G. Drachman Director, President and CEO Purchase of securities on an exchange or from another person at price $ 8.40 per share. 12 Nov 2019 119,047 2,198,686 (4%) 0% 8.4 999,995 Common Stock
Jonathan G. Drachman Director, President and CEO 12 Nov 2019 1,261,600 2,079,639 (5%) 3% 0 Common Stock
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 22,000 22,000 - - Stock Option (right to buy)
Lewis T. Williams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 22,000 22,000 - - Stock Option (right to buy)
Sean P. Nolan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 22,000 22,000 - - Stock Option (right to buy)
Sarah B. Noonberg None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2019 22,000 22,000 - - Stock Option (right to buy)
Jonathan G. Drachman Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.85 per share. 09 Sep 2019 76,822 411,250 (1%) 0% 2.8 218,559 Common Stock
Jonathan G. Drachman Director, See Remarks Purchase of securities on an exchange or from another person at price $ 3.30 per share. 09 Sep 2019 136,436 584,428 (2%) 0% 3.3 449,898 Common Stock
Jonathan G. Drachman Director, See Remarks Purchase of securities on an exchange or from another person at price $ 3.08 per share. 09 Sep 2019 36,742 447,992 (1%) 0% 3.1 113,290 Common Stock
Jonathan G. Drachman Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2019 1,650,000 1,650,000 - - Stock Option (Right to Buy)
Jonathan G. Drachman Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2019 12,616 12,616 (0%) 0% 0 Series A Preferred Stock
Jonathan G. Drachman Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Aug 2019 568,039 568,039 (2%) 2% 0 Common Stock
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2018 415,000 415,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2018 195,000 195,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2018 145,000 145,000 - - Stock Option (Right to Buy)
Shelley McCloskey VP, HR and Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2018 75,000 75,000 - - Stock Option (Right to Buy)
Daniel J. Levitt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 May 2018 3,906 0 - - Stock Option (Right to Buy)
Daniel J. Levitt None Sale of securities on an exchange or to another person at price $ 12.67 per share. 14 May 2018 3,906 0 (0%) 0% 12.7 49,489 Common Stock
Daniel J. Levitt None Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.56 per share. 14 May 2018 3,906 3,906 (0%) 0% 10.6 41,247 Common Stock
Daniel J. Levitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2018 15,000 15,000 - - Stock Option (Right to Buy)
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2018 15,000 15,000 - - Stock Option (Right to Buy)
Robert E. Pelzer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2018 15,000 15,000 - - Stock Option (Right to Buy)
Sean P. Nolan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2018 15,000 15,000 - - Stock Option (Right to Buy)
Gary J. Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2018 15,000 15,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.56 per share. 15 Mar 2018 1,302 1,302 (0%) 0% 10.6 13,749 Common Stock
Lloyd Mackenzie Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2018 1,302 0 - - Stock Option (Right to Buy)
Lloyd Mackenzie Chief Operating Officer Sale of securities on an exchange or to another person at price $ 14.63 per share. 15 Mar 2018 1,302 0 (0%) 0% 14.6 19,049 Common Stock
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 225,000 225,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 75,000 75,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 75,000 75,000 - - Stock Option (Right to Buy)
Barbara Troupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 75,000 75,000 - - Stock Option (Right to Buy)
Shelley McCloskey VP, HR and Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 45,000 45,000 - - Stock Option (Right to Buy)
Abigail Jenkins Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2018 75,000 75,000 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2017 6,000 3,625 - - Stock Option (Right to Buy(
David J. Main Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.16 per share. 01 Jun 2017 3,625 71,530 (0%) 0% 13.2 47,696 Common Stock
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.60 per share. 01 Jun 2017 3,625 75,155 (0%) 0% 9.6 34,800 Common Stock
David J. Main Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.59 per share. 01 Jun 2017 6,000 71,530 (0%) 0% 13.6 81,560 Common Stock
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.60 per share. 01 Jun 2017 6,000 77,530 (0%) 0% 9.6 57,600 Common Stock
David J. Main Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.00 per share. 01 Jun 2017 6,000 71,530 (0%) 0% 13.0 77,988 Common Stock
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.60 per share. 01 Jun 2017 6,000 77,530 (0%) 0% 9.6 57,600 Common Stock
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2017 3,625 0 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2017 6,000 9,625 - - Stock Option (Right to Buy)
Daniel J. Levitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2017 9,000 9,000 - - Stock Option (Right to Buy)
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2017 9,000 9,000 - - Stock Option (Right to Buy)
Robert E. Pelzer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2017 9,000 9,000 - - Stock Option (Right to Buy)
Sean P. Nolan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2017 9,000 9,000 - - Stock Option (Right to Buy)
Gary J. Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2017 9,000 9,000 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 185,000 185,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 80,000 80,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 50,000 50,000 - - Stock Option (Right to Buy)
Barbara Troupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 40,000 40,000 - - Stock Option (Right to Buy)
David Chilton Mitchell VP Global Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 25,000 25,000 - - Stock Option (Right to Buy)
Shelley McCloskey VP, HR and Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 30,000 30,000 - - Stock Option (Right to Buy)
Abigail Jenkins Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2017 80,000 80,000 - - Stock Option (Right to Buy)
Shelley McCloskey VP, HR and Administration 31 Dec 2016 35,000 35,000 - - Stock Option (Right to Buy)
Barbara Troupin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Nov 2016 50,000 50,000 - - Stock Option (Right to Buy)
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Sep 2016 294,707 1,119,075 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Sep 2016 2,476,348 9,404,467 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Sep 2016 12,550 1,131,625 - - Common Stock
Abigail Jenkins Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2016 50,000 50,000 - - Stock Option (Right to Buy)
Daniel J. Levitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Robert E. Pelzer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Sean P. Nolan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Gary Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 May 2016 7,500 7,500 - - Stock Option (Right to Buy)
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 3,374 781,421 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 30,986 6,533,759 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 7,420 788,841 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 68,132 6,601,891 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 1,289 790,130 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 11,840 6,613,731 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 20,192 810,322 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 185,413 6,799,144 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 14,046 824,368 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Mar 2016 128,975 6,928,119 - - Common Stock
Stephen B. Shrewsbury CMO; Senior VP Clinical Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2016 35,000 35,000 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2016 120,000 120,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2016 40,000 40,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2016 35,000 35,000 - - Stock Option (Right to Buy)
David Chilton Mitchell VP Global Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2016 25,000 25,000 - - Stock Option (Right to Buy)
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 1,887 765,980 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 17,221 6,393,162 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 440 766,420 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 4,021 6,397,183 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 17 766,437 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 156 6,397,339 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 2,810 769,247 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 25,650 6,422,989 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 312 769,559 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 2,833 6,425,822 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 497 770,056 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 4,503 6,430,325 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 278 770,334 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 2,522 6,432,847 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 7,318 777,652 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 66,345 6,499,192 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 395 778,047 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jan 2016 3,581 6,502,773 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 5,029 750,354 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 45,903 6,250,533 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 1,109 751,463 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 10,123 6,260,656 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 1,568 753,031 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 14,313 6,274,969 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 6,294 759,325 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 57,453 6,332,422 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 1,511 760,836 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 13,789 6,346,211 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 3,067 763,903 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 27,996 6,374,207 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 190 764,093 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Jan 2016 1,734 6,375,941 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 9,970 735,198 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 90,550 6,112,654 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 1,399 736,597 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 12,706 6,125,360 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 330 736,927 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 2,998 6,128,358 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 2,296 739,223 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 20,851 6,149,209 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 361 739,584 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 3,279 6,152,488 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 545 740,129 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 4,949 6,157,437 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 5,196 745,325 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jan 2016 47,193 6,204,630 - - Common Stock
Gary Bridger None Other type of transaction at price $ 0.00 per share. 31 Oct 2015 1,543,989 0 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Sep 2015 266,563 725,228 - - Common Stock
Julian C. Baker Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Sep 2015 2,213,469 6,022,104 - - Common Stock
David Chilton Mitchell VP Global Regulatory & Quality Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2015 3,575 3,575 - - Common Stock
Kamran Alam CFO, Vice President Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 8,246 2,170 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 20,833 0 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 8,246 8,246 - - Common Stock
Kamran Alam CFO, Vice President Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 20,833 29,079 - - Common Stock
Kamran Alam CFO, Vice President Finance Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Aug 2015 29,079 0 - - Common Stock
Lloyd Mackenzie VP Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 7,812 0 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 28,075 1,872 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 7,812 7,812 - - Common Stock
Lloyd Mackenzie VP Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Aug 2015 28,075 35,887 - - Common Stock
Lloyd Mackenzie VP Technical Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Aug 2015 35,887 0 - - Common Stock
David Chilton Mitchell VP Global Regulatory & Quality Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Aug 2015 1,600 1,600 - - Common Stock
Daniel J. Levitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 5,000 5,000 - - Stock Option (Right to Buy)
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 5,000 5,000 - - Stock Option (Right to Buy)
Robert E. Pelzer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 5,000 5,000 - - Stock Option (Right to Buy)
Stephen B. Shrewsbury CMO; Senior VP Clinical Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 25,000 25,000 - - Stock Option (Right to Buy)
Sean P. Nolan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 10,000 10,000 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 65,000 65,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 25,000 25,000 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 25,000 25,000 - - Stock Option (Right to Buy)
Gary Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2015 5,000 5,000 - - Stock Option (Right to Buy)
David Chilton Mitchell VP Global Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2015 35,000 35,000 - - Stock Option (Right to Buy)
Stephen B. Shrewsbury CMO; Senior VP Clinical Dev. Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Dec 2014 400 400 - - Common Stock
Stephen B. Shrewsbury CMO; Senior VP Clinical Dev. Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 31,250 31,250 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 65,000 65,000 - - Stock Option (Right to Buy)
Kamran Alam CFO, Vice President Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 31,250 31,250 - - Stock Option (Right to Buy)
Lloyd Mackenzie VP Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 May 2014 25,000 25,000 - - Stock Option (Right to Buy)
David J. Main Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 9,459 0 - - Common Exchangeable Shares
David J. Main Director, President and CEO 12 Mar 2014 71,530 0 - - Common Exchangeable Shares
David J. Main Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 9,459 71,530 - - Common Special Voting Stock
David J. Main Director, President and CEO 12 Mar 2014 71,530 0 - - Common Special Voting Stock
David J. Main Director, President and CEO 12 Mar 2014 71,530 71,530 - - Common Stock
Gary Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2014 36,502 40,147 - - Common Exchangeable Shares
Gary Bridger None 12 Mar 2014 40,147 0 - - Common Exchangeable Shares
Gary Bridger None 12 Mar 2014 284,090 0 - - Series A-1 Exchangeable Shares
Gary Bridger None 12 Mar 2014 284,090 0 - - Series A-1 Preferred Stock
Gary Bridger None 12 Mar 2014 284,090 0 - - Series A-1 Preferred Stock
Gary Bridger None 12 Mar 2014 189,393 0 - - Series A-2 Exchangeable Shares
Gary Bridger None 12 Mar 2014 189,393 0 - - Series A-2 Preferred Stock
Gary Bridger None 12 Mar 2014 189,393 0 - - Series A-2 Preferred Stock
Gary Bridger None 12 Mar 2014 326,538 0 - - Series B-1 Exchangeable Shares
Gary Bridger None 12 Mar 2014 326,538 0 - - Series B-1 Preferred Stock
Gary Bridger None 12 Mar 2014 326,538 0 - - Series B-1 Preferred Stock
Gary Bridger None 12 Mar 2014 325,035 0 - - Series B-2 Exchangeable Shares
Gary Bridger None 12 Mar 2014 325,035 0 - - Series B-2 Preferred Stock
Gary Bridger None 12 Mar 2014 325,035 0 - - Series B-2 Preferred Stock
Gary Bridger None 12 Mar 2014 378,786 0 - - Series C Exchangeable Shares
Gary Bridger None 12 Mar 2014 378,786 0 - - Series C Preferred Stock
Gary Bridger None 12 Mar 2014 378,786 0 - - Series C Preferred Stock
Gary Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2014 36,502 40,147 - - Common Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 40,147 0 - - Common Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 284,090 0 - - Series A-1 Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 189,393 0 - - Series A-2 Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 326,538 0 - - Series B-1 Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 325,035 0 - - Series B-2 Special Voting Stock
Gary Bridger None Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Mar 2014 378,786 0 - - Series C Special Voting Stock
Gary Bridger None 12 Mar 2014 1,543,989 1,543,989 - - Common Stock
Daniel J. Levitt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 8,333 20,051 - - Stock Option (Right to Buy)
Todd E. Simpson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 8,333 8,333 - - Stock Option (Right to Buy)
Robert E. Pelzer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 8,333 14,843 - - Stock Option (Right to Buy)
Gary Bridger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 8,333 8,333 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters